Treatment of Polyarticular Gout Arthritis
For acute polyarticular gout flares, initiate treatment immediately with colchicine (1.2 mg followed by 0.6 mg one hour later), NSAIDs, or glucocorticoids as first-line therapy, with the choice driven by patient comorbidities and contraindications 1.
Acute Flare Management
The 2020 ACR guidelines strongly recommend colchicine, NSAIDs, or glucocorticoids as preferred first-line therapies based on substantial trial data demonstrating efficacy and tolerability 1. These agents show similar efficacy (79-88% response rates), so selection depends on patient-specific factors:
First-Line Options:
Colchicine: FDA-approved dosing is 1.2 mg immediately, then 0.6 mg one hour later, continuing until flare resolves 1. Critical caveat: Adjust doses for renal function, hepatic dysfunction, and drug interactions—this is a common pitfall leading to toxicity 2, 3.
NSAIDs: Effective alternative when colchicine is contraindicated, but frequently limited by comorbidities (renal disease, cardiovascular disease, GI issues) 1, 4.
Glucocorticoids:
Second-Line Options:
- IL-1 inhibitors (anakinra, canakinumab): Conditionally recommended when colchicine, NSAIDs, and glucocorticoids are ineffective, poorly tolerated, or contraindicated 1, 4. The 2017 EULAR guidelines specifically recommend considering IL-1 blockers for patients with frequent flares and contraindications to all conventional therapies 4.
Adjuvant Therapy:
- Topical ice: Conditionally recommended as adjuvant treatment 1
Long-Term Management Strategy
Beyond treating the acute flare, you must initiate urate-lowering therapy (ULT) to prevent future polyarticular episodes and achieve disease cure 4.
When to Start ULT:
The 2017 EULAR guidelines recommend considering ULT from the first presentation of disease 4. More conservatively, initiate ULT in patients with:
- ≥2 flares per year
- Tophi (subcutaneous or radiographic)
- Radiographic evidence of gouty arthropathy 5
ULT Targets:
- Standard target: Serum uric acid <6 mg/dL (360 μmol/L) 4
- Severe gout with tophi: Target <5 mg/dL (300 μmol/L) for prompt crystal dissolution 4, 5
ULT Algorithm:
First-line: Allopurinol - Start low and titrate up, adjusting for renal function 4. Common pitfall: Stopping at 300 mg/day when higher doses are needed and safe with proper renal adjustment 3.
If allopurinol fails to achieve target: Switch to febuxostat, add a uricosuric (probenecid if CrCl >50 mL/min), or combine xanthine oxidase inhibitor with uricosuric 1, 4.
Refractory gout: The 2020 ACR guidelines strongly recommend switching to pegloticase for patients with frequent flares or nonresolving tophi when XOI, uricosurics, and other interventions have failed 1.
Flare Prophylaxis During ULT Initiation:
Mandatory prophylaxis for 3-6 months when starting ULT to prevent precipitating flares 2, 6. Use low-dose colchicine as first choice.
Special Considerations for Polyarticular Presentation
Polyarticular gout often masquerades as rheumatoid arthritis, septic arthritis, or other conditions 7. Key diagnostic clues include:
- History of intermittent acute gout
- Prior polyarticular attacks
- Previous hyperuricemia
- Obvious tophi 7
Patients with polyarticular gout frequently have:
These patients are the most challenging to treat and should be co-managed with a rheumatologist 2.
Lifestyle Modifications:
While treating pharmacologically, implement:
- Weight loss (if overweight)
- Limit alcohol intake (conditionally recommended) 1
- Limit purine-rich foods (conditionally recommended) 1
- Discontinue diuretics if possible 3
- Consider losartan for hypertension and fenofibrate for dyslipidemia (both have uricosuric effects) 3
Critical Implementation Points:
Start anti-inflammatory therapy early—the Patient Panel in the ACR guidelines emphasized preference for "medication-in-pocket" strategy for patients who recognize early flare signs 1. For polyarticular flares specifically, systemic corticosteroids may be necessary when multiple joints are involved 3. Never delay treatment to confirm diagnosis with joint aspiration if clinical suspicion is high and septic arthritis is excluded.